This 2017 review evaluates the potential of detecting methylated circulating cell-free DNA (cfDNA) in peripheral blood as a noninvasive diagnostic tool for breast cancer. Analyzing 14 studies, the authors highlight that multi-gene methylation panels enhance diagnostic sensitivity and specificity compared to single-gene analyses. Techniques such as methylation-specific PCR and digital
